 Bragar Eagel Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Fennec Pharmaceuticals, Inc. NASDAQ: FENC on behalf of Fennec stockholders. Our investigation concerns whether Fennec has violated the federal securities laws andor engaged in other unlawful business practices. 